Literature DB >> 26388917

Laparoscopic left hepatectomy in patients with intrahepatic duct stones and recurrent pyogenic cholangitis.

Sunjong Han1, Insang Song1, Kwangsik Chun1.   

Abstract

BACKGROUNDS/AIMS: Recently many studies have been reported the early results of a hepatectomy for various intrahepatic lesions. Also various types of laparoscopic hepatectomies are being performed in many centers. Some reports about the safety of laparoscopic parenchymal dissection of the liver have been published. In this study, we reported our experiences of laparoscopic left hepatectomies in patients with an intrahepatic duct (IHD) stone with recurrent pyogenic cholangitis (RPC), and investigated whether the total laparoscopic parenchymal dissection is as safe as open surgery.
METHODS: From April 2008 to December 2010, 25 patients had been admitted for left IHD stones with RPC. Preoperatively, the type of surgery was decided with the intention of treating each patient. Initially 10 patients underwent a laparoscopy-assisted left hepatectomy and the next 15 patients underwent total laparoscopic left hepatectomy as our experience grew. Demographics, peri- and postoperative results were collected and analyzed comparatively.
RESULTS: The mean age, gender ratio, preoperative American Society of Anesthesiologists (ASA) score, accompanied acute cholangitis and biliary pancreatitis, and the number of preoperative percutaneous transhepatic biliary drainage (PTBD) inserted cases were not different between the two groups who had undergone laparoscopy-assisted and totally laparoscopic left hepatectomy. The operation time, intraoperative transfusions and postoperative complications also showed no difference between them. The postoperative hospital stay did not show a significant difference statistically.
CONCLUSIONS: In this study, we concluded that a laparoscopic left hepatectomy can be adapted to the patients with a left IHD stone with RPC. Also laparoscopic parenchymal dissection is safe and equivalent to an open procedure.

Entities:  

Keywords:  Intrahepatic duct stone; Laparoscopic left hepatectomy; Recurrent pyogenic cholangitis

Year:  2012        PMID: 26388917      PMCID: PMC4575009          DOI: 10.14701/kjhbps.2012.16.3.105

Source DB:  PubMed          Journal:  Korean J Hepatobiliary Pancreat Surg        ISSN: 1738-6349


  9 in total

1.  Laparoscopic hepatectomy for hepatolithiasis: a feasibility and safety study in 29 patients.

Authors:  Xiujun Cai; Yifan Wang; Hong Yu; Xiao Liang; Shuyou Peng
Journal:  Surg Endosc       Date:  2007-05-22       Impact factor: 4.584

2.  Laparoscopic liver resections.

Authors:  C G Hüscher; M M Lirici; S Chiodini
Journal:  Semin Laparosc Surg       Date:  1998-09

Review 3.  Laparoscopic resection of a large hepatic tumor.

Authors:  G Ferzli; A David; T Kiel
Journal:  Surg Endosc       Date:  1995-06       Impact factor: 4.584

4.  Laparoscopic partial hepatectomy and left lateral segmentectomy: technique and results of a clinical series.

Authors:  H Kaneko; S Takagi; T Shiba
Journal:  Surgery       Date:  1996-09       Impact factor: 3.982

5.  Risk factors for recurrent cholangitis after initial hepatolithiasis treatment.

Authors:  Jin-Hyeok Hwang; Yong Bum Yoon; Yong-Tae Kim; Jae Hee Cheon; Ji Bong Jeong
Journal:  J Clin Gastroenterol       Date:  2004-04       Impact factor: 3.062

6.  Primary biliary stones: diagnosis and management.

Authors:  C L Liu; S T Fan; J Wong
Journal:  World J Surg       Date:  1998-11       Impact factor: 3.352

7.  A reappraisal of cholangiocarcinoma in patient with hepatolithiasis.

Authors:  M F Chen; Y Y Jan; C S Wang; T L Hwang; L B Jeng; S C Chen; T J Chen
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

8.  Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound.

Authors:  T G John; J D Greig; J L Crosbie; W F Miles; O J Garden
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

9.  Hepatolithiasis associated with cholangiocarcinoma.

Authors:  S Kubo; H Kinoshita; K Hirohashi; H Hamba
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.